NPPA notified regarding the fixation of the retail price of Linagliptin IP 5mg + Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 10mg + Metformin Hydrochloride (as sustained release form) IP 500mg

Aug 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 31, 2024, notified regarding the fixation of the retail price of Linagliptin IP 5mg + Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 10mg + Metformin Hydrochloride (as sustained release form) IP 500mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 10.21/- for the Composition of each film coated bilayered tablet contains: Linagliptin 5mg.

• It has fixed the rate at Rs. 10.75/- for the Composition of each film coated bilayered tablet contains: Dapagliflozin 10mg + Metformin 1000mg.

• It has fixed the rate at Rs. 12.10/- for the Composition of each film coated bilayered tablet contains: Dapagliflozin 10mg.

[Notification no. - 19(4141)/2024/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT